| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Environmental Epidemiology, Institute of Environmental Medicine, Karolinska Institute, S-171 77 Stockholm, [A. Y., G. P.]; Department of Biotechnology, KTH, Royal Institute of Technology, S-10044 Stockholm, [C. W., J. L.]; Department of Immunology, Microbiology, Pathology, and Infectious Diseases, Division of Pathology, Huddinge University Hospital, S-14186 Stockholm, [A. H.]; and Department of Cell Biology, Faculty of Health Sciences, S-58185 Linköping, [P. S.] Sweden
Unusual mutation patterns in lung tumors among underground miners have been indicated, suggesting radon-specific alterations in the genome, but the data are not consistent. To investigate the association between residential radon exposure and p53 mutations in lung tumors, we performed a study on cases from a nation-wide population-based investigation in Sweden. Our study included 83 nonsmoking lung cancer cases and 250 smoking lung cancer cases, diagnosed 19801984, with a time-weighted average radon exposure over 140 Bq/m3 or up to 50 Bq/m3. Radon was measured in dwellings occupied by the study subjects at some time since 1947. Information on smoking habits and other risk factors was obtained from questionnaires. After exclusions because of the initiation of treatment or insufficient material, the p53-status of 243 tumors was determined using PCR-single-stranded conformation polymorphism analysis and sequencing determination of exons 58. The overall mutation prevalence was 23.9%. An increased mutation prevalence was suggested among those with high exposure to residential radon [odds ratio (OR), 1.4; 95% CI, 0.72.6], especially among nonsmokers (OR, 3.2; 95% CI, 0.715.5), but no specific mutational pattern was indicated. Furthermore, the mutation prevalence seemed to be higher among smoking lung cancer cases than among nonsmoking cases (OR, 2.1; 95% CI, 0.95.0), and particularly among those smoking less than 10 cigarettes per day. It may be concluded that residential exposure to radon seems to contribute to a higher mutation prevalence of the p53 gene in lung tumors.
This article has been cited by other articles:
![]() |
A. Ruano-Ravina, R. Perez-Becerra, M. Fraga, K. T. Kelsey, and J. M. Barros-Dios Analysis of the relationship between p53 immunohistochemical expression and risk factors for lung cancer, with special emphasis on residential radon exposure Ann. Onc., January 1, 2008; 19(1): 109 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Barros-Dios, M. A. Barreiro, A. Ruano-Ravina, and A. Figueiras Exposure to Residential Radon and Lung Cancer in Spain: A Population-based Case-Control Study Am. J. Epidemiol., September 15, 2002; 156(6): 548 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Vahakangas, W. P. Bennett, K. Castren, J. A. Welsh, M. A. Khan, B. Blomeke, M. C. R. Alavanja, and C. C. Harris p53 and K-ras Mutations in Lung Cancers from Former and Never-Smoking Women Cancer Res., June 1, 2001; 61(11): 4350 - 4356. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hainaut and G. P. Pfeifer Patterns of p53 G{->}T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke Carcinogenesis, March 1, 2001; 22(3): 367 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Husgafvel-Pursiainen, P. Boffetta, A. Kannio, F. Nyberg, G. Pershagen, A. Mukeria, V. Constantinescu, C. Fortes, and S. Benhamou p53 Mutations and Exposure to Environmental Tobacco Smoke in a Multicenter Study on Lung Cancer Cancer Res., June 1, 2000; 60(11): 2906 - 2911. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Williams, F. Ponten, C. Moberg, P. Soderkvist, M. Uhlen, J. Ponten, G. Sitbon, and J. Lundeberg A High Frequency of Sequence Alterations Is Due to Formalin Fixation of Archival Specimens Am. J. Pathol., November 1, 1999; 155(5): 1467 - 1471. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |